Serum complement factor I is associated with disease activity of systemic lupus erythematosus

Although aberrant complement activation is involved in the pathogenesis of systemic lupus erythematosus (SLE), the role of complement regulatory proteins in disease activity of SLE remains limited. We enrolled the pediatric-onset SLE patients from our cohort study over 10 years. The clinical and lab...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Tseng, Min-Hua, Lin, Shih-Hua, Wu, Chao-Yi, Chien, Hui-Ping, Yang, Huang-Yu, Chen, Yung-Chang, Chou, Yu-Ching, Huang, Jing-Long
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2018
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5823600/
https://ncbi.nlm.nih.gov/pubmed/29492211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23907
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars